Lataa...
Differential PD-1/LAG-3 expression and immune phenotypes in metastatic sites of breast cancer
BACKGROUND: A dual blockade against the novel immune checkpoint inhibitor lymphocyte activation gene-3 (LAG-3) and programmed cell death protein-1 (PD-1) is currently considered in advanced breast cancer. Nevertheless, PD-1 or LAG-3 expression within distant metastatic breast cancer tissue remains u...
Tallennettuna:
| Julkaisussa: | Breast Cancer Res |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7792100/ https://ncbi.nlm.nih.gov/pubmed/33413541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-020-01380-w |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|